2021
DOI: 10.1016/j.cell.2020.11.035
|View full text |Cite
|
Sign up to set email alerts
|

TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 62 publications
0
19
0
Order By: Relevance
“…described CD5 expression as a marker of DE cells and detected higher proportions in T1D patients as compared with controls. These findings were recently challenged by Japp et al 16 . who did not find higher proportions of DE cells in T1D patients and questioned lineage integrity of DE cells.…”
Section: Discussionmentioning
confidence: 94%
“…described CD5 expression as a marker of DE cells and detected higher proportions in T1D patients as compared with controls. These findings were recently challenged by Japp et al 16 . who did not find higher proportions of DE cells in T1D patients and questioned lineage integrity of DE cells.…”
Section: Discussionmentioning
confidence: 94%
“…Dual expression of Ig and TCRs or other B and T cell markers have been reported by others, but the role that these hybrid lymphocytes play is largely unknown. 33-35 The possibility of doublets, where two cells are given the same cellular barcode, does arise when using droplet-based single cell technologies such as the 10x Genomics used here. To assess the potential for these cells to be B+T cell doublets we used differential expression analysis to identify transcriptomic signatures that were absent in B and T cells.…”
Section: Resultsmentioning
confidence: 99%
“…It is suggested that these "dual expressors" (DE) are increased in frequency in type 1 diabetes and that in people with type 1 diabetes there is a public BCR which can stimulate insulin-reactive CD4+ T cells. However, this work remains controversial as others have been unable to replicate the enrichment of DE in T1D nor the specific public BCR sequence (75). This highlights the importance of good quality control at every step of scRNAseq experiments.…”
Section: Identifying Islet-reactive Bcrs In the Periphery Pancreatic Lymph Nodes And Pancreasmentioning
confidence: 99%